Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal de Mycologie Médicale

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mycmed.2014.12.002PMID 25639922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B

  2014cited by this paper
• Mechanism of activity and toxicity of Nystatin-Intralipid.

  2013cited by this paper
• Invasive fungal infections.

  2013cited by this paper
• Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

  2012cited by this paper
• Invasive fungal infections in patients with cancer in the Intensive Care Unit.

  2012cited by this paper
• Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice.

  2012cited by this paper
• Susceptibility Test Methods: Yeasts and Filamentous Fungi*

  2011cited by this paper
• Current concepts in antifungal pharmacology.

  2011cited by this paper
• Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations

  2011cited by this paper
• Activity of an Intralipid formulation of nystatin in murine systemic candidiasis.

  2011cited by this paper
• Antifungal therapy.

  2011cited by this paper
• Nystatin-Intralipid Preparation: Characterization and In Vitro Activity Against Yeasts and Molds

  2010influential reference
• Update on antifungal therapy with terbinafine.

  2010cited by this paper
• Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

  2010cited by this paper
• Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

  2008cited by this paper
• Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.

  2008cited by this paper
• Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies

  2007cited by this paper
• Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.

  2006cited by this paper
• Combination Treatment of Invasive Fungal Infections

  2005cited by this paper
• Epidemiology and outcome of infections due to Aspergillus terreus: 10‐year single centre experience

  2005cited by this paper
• Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.

  2004cited by this paper
• Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.

  2004cited by this paper
• Development of liposomal polyene antibiotics: an historical perspective.

  2003cited by this paper
• In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

  2002cited by this paper
• Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice.

  2001cited by this paper
• Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.

  1999cited by this paper
• Antifungal combination therapy: where we stand.

  1998cited by this paper
• The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures.

  1997cited by this paper
• Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro

  1995cited by this paper
• Medically important fungi

  1994cited by this paper
• Manual of clinical microbiology

  1975cited by this paper
• “Nystatin”

  1956cited by this paper

• A naturally isolated symbiotic Lactobacillus murinus suppresses multidrug-resistant Campylobacter jejuni via microbial metabolites

  2025cites this paper
• Efficacy and Molecular Mechanisms of Nystatin Against Botrytis cinerea on Postharvest Table Grape

  2024cites this paper
• Antifúngicos: lo que tenemos, lo que tendremos, lo que queremos.

  2023cites this paper
• Reviving the interest in the versatile drug nystatin: a multitude of strategies to increase its potential as an effective and safe antifungal agent.

  2023cites this paper
• Diagnostic Approaches for Aspergillus Infections

  2019cites this paper
• Antifungals discovery: an insight into new strategies to combat antifungal resistance

  2018cites this paper
• Risk Assessment Integrated QbD Approach for Development of Optimized Bicontinuous Mucoadhesive Limicubes for Oral Delivery of Rosuvastatin

  2018cites this paper
• Diagnostic Aspects of Veterinary and Human Aspergillosis

  2018cites this paper
• In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes

  2018cites this paper
• SYNTHESIS, SPECTRAL STUDIES, STRUCTURAL EVALUATION AND ANTIMICROBIAL ACTIVITY OF SOME NOVEL C R(III) COMPLEXES CONTAINING TETRADENTATE MACROCYCLIC LIGANDS

  2017cites this paper
• Recent Advancements in Combinational Antifungal Therapy and Immunotherapy

  2016cites this paper
• Cryptic antifungal compounds active by synergism with polyene antibiotics.

  2016cites this paper
• Recent advances in the identification and the study of composition and activities of medicinal plants

  2016cites this paper
• A STUDY ON ANTI-DERMATOPHYTES ACTIVITY IN VITRO OF TURMERIC ESSENTIAL OIL

  year unknowncites this paper